Continuous Intravenous Morphine Infusion: Evidence‑Based Initiation, Titration, and Dosing Guidelines

Initiation and Rapid Titration

Start‑up dosing for opioid‑naïve patients: give 1–2 mg subcutaneously or intravenously every 2–4 h as needed; for rapid control of severe pain administer 1.5 mg IV bolus every 10 min until relief, then begin a continuous infusion at an hourly rate equal to 50 % of the cumulative bolus dose. 1 (NCCN)
Rapid IV titration protocol: assess analgesic effect and adverse events every 15 min during IV bolus administration to guide subsequent dosing. [1][2] (NCCN; Annals of Oncology)
Conversion ratio: 1 mg IV morphine ≈ 3 mg oral morphine (IV : oral = 1 : 3). [2][3] (Annals of Oncology; NCCN)

Breakthrough‑pain rescue dose: prescribe rescue doses equal to 10–15 % of the total daily morphine dose. [2][4] (Annals of Oncology)
If > 4 rescue doses are needed in 24 h: increase the basal continuous‑infusion rate. [2][4] (Annals of Oncology)
When rotating opioids, reduce the calculated equianalgesic dose by 25–50 % to account for incomplete cross‑tolerance. 2 (Annals of Oncology)

Definition of tolerance: ≥60 mg oral morphine daily (or an equianalgesic dose of another opioid) for at least one week. 1 (NCCN)
Dosing for tolerant patients: calculate the morphine‑equivalent daily dose (MEDD) from the previous 24 h and increase rescue doses by 10–20 % to achieve adequate analgesia; reassess every 15 min during IV administration and adjust accordingly. 1 (NCCN)

Mild renal impairment (GFR 30–60 mL/min): reduce the initial morphine dose by 25–50 % and extend the dosing interval to every 6–8 h. 5 (Praxis)
Severe renal impairment or dialysis (GFR <30 mL/min): avoid morphine; use IV fentanyl as first‑line opioid (initial 25–50 µg over 1–2 min, repeat every 5 min as needed). [6][7] (Praxis)
Buprenorphine transdermal is recommended as the safest option for patients on dialysis according to ESMO. 6 (Praxis referencing ESMO)

In hepatic insufficiency: start morphine at 50 % of the standard dose, titrate slowly with close monitoring, and consider longer dosing intervals because of a potentially prolonged half‑life. 3 (NCCN)

During IV titration: monitor respiratory rate, level of sedation, and blood pressure every 15 min. 1 (NCCN)
Clinical monitoring: assess pain intensity with standardized scales before and after each dose adjustment. 7 (Praxis)
Bowel regimen: prescribe a stimulant laxative (e.g., senna) with or without a stool softener for all patients receiving opioids. [1][3] (NCCN)
Naloxone availability: keep naloxone on hand to reverse severe opioid‑induced respiratory depression. 7 (Praxis)
Antiemetic prophylaxis: consider a prophylactic antiemetic such as haloperidol when initiating opioid therapy. 8 (BMJ)

Subcutaneous continuous infusion is as effective as IV infusion with a comparable adverse‑event profile; however, the IV route provides faster analgesia and is preferred for rapid titration. 2 (Annals of Oncology)